{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T16:10:12Z","timestamp":1758989412515,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.jinf.2005.08.025","type":"journal-article","created":{"date-parts":[[2005,10,25]],"date-time":"2005-10-25T08:44:45Z","timestamp":1130229885000},"page":"389-398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Growth factors, glucose and insulin kinetics after low dose growth hormone therapy in HIV-lipodystrophy"],"prefix":"10.1016","volume":"52","author":[{"given":"Steen B.","family":"Haugaard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ove","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Flyvbjerg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"\u00d8rskov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sten","family":"Madsbad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2005.08.025_bib1","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2005.08.025_bib2","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1210\/jc.2002-020794","article-title":"Clinical review 153: lipodystrophy in human immunodeficiency virus-infected patients","volume":"87","author":"Chen","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jinf.2005.08.025_bib3","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0140-6736(03)12656-6","article-title":"An objective case definition of lipodystrophy in HIV-infected adults: a case\u2013control study","volume":"361","author":"Carr","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2005.08.025_bib4","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0026-0495(03)00201-4","article-title":"Lipodystrophy in human immunodeficiency virus patients impairs insulin action and induces defects in beta-cell function","volume":"52","author":"Andersen","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.jinf.2005.08.025_bib5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1086\/317541","article-title":"Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy","volume":"32","author":"Hadigan","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2005.08.025_bib6","doi-asserted-by":"crossref","first-page":"E677","DOI":"10.1152\/ajpendo.00009.2004","article-title":"Insulin secretion in lipodystrophic HIV-infected patients is associated with high levels of nonglucose secretagogues and insulin resistance of {beta}-cells","volume":"287","author":"Haugaard","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jinf.2005.08.025_bib7","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1097\/00002030-200110190-00012","article-title":"Fat distribution and metabolic changes are strongly correlated and energy expenditure is increased in the HIV lipodystrophy syndrome","volume":"15","author":"Kosmiski","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2005.08.025_bib8","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00126334-200012010-00004","article-title":"Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy","volume":"25","author":"Mynarcik","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jinf.2005.08.025_bib9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00042560-200208010-00002","article-title":"Effect of recombinant human growth hormone in the treatment of visceral fat accumulation in HIV infection","volume":"30","author":"Engelson","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jinf.2005.08.025_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00126334-200403010-00004","article-title":"Effects of growth hormone on abnormal visceral adipose tissue accumulation and dyslipidemia in HIV-infected patients","volume":"35","author":"Kotler","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jinf.2005.08.025_bib11","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1210\/jcem.86.8.7785","article-title":"The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation","volume":"86","author":"Lo","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jinf.2005.08.025_bib12","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1086\/422725","article-title":"The effects of low-dose growth hormone in HIV-infected men with fat accumulation: a pilot study","volume":"39","author":"Lo","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2005.08.025_bib13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2362.2004.01380.x","article-title":"Low-dose growth hormone and human immunodeficiency virus-associated lipodystrophy syndrome: a pilot study","volume":"34","author":"Andersen","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jinf.2005.08.025_bib14","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(00)04056-3","article-title":"Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study","volume":"357","author":"Martinez","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2005.08.025_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0168-8227(99)00008-X","volume":"44","author":"Puavilai","year":"1999","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jinf.2005.08.025_bib16","first-page":"1312","article-title":"Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women","volume":"78","author":"Chapman","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jinf.2005.08.025_bib17","first-page":"E214","article-title":"Glucose clamp technique: a method for quantifying insulin secretion and resistance","volume":"237","author":"DeFronzo","year":"1979","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jinf.2005.08.025_bib18","first-page":"169","article-title":"Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II","volume":"5","author":"Frystyk","year":"1995","journal-title":"Growth Regul"},{"key":"10.1016\/j.jinf.2005.08.025_bib19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0014-5793(94)00602-4","article-title":"Free insulin-like growth factors (IGF-I and IGF-II) in human serum","volume":"348","author":"Frystyk","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jinf.2005.08.025_bib20","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1152\/jappl.1983.55.2.628","article-title":"Calculation of substrate oxidation rates in vivo from gaseous exchange","volume":"55","author":"Frayn","year":"1983","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.jinf.2005.08.025_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0169-2607(96)01755-5","article-title":"ISEC: a program to calculate insulin secretion","volume":"50","author":"Hovorka","year":"1996","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.jinf.2005.08.025_bib22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.jinf.2005.08.025_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.metabol.2004.08.009","article-title":"In nondiabetic, human immunodeficiency virus-infected patients with lipodystrophy, hepatic insulin extraction and posthepatic insulin clearance rate are decreased in proportion to insulin resistance","volume":"54","author":"Haugaard","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.jinf.2005.08.025_bib24","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.metabol.2004.06.025","article-title":"Insulin-like growth factors, insulin-like growth factor-binding proteins, insulin-like growth factor-binding protein-3 protease, and growth hormone-binding protein in lipodystrophic human immunodeficiency virus-infected patients","volume":"53","author":"Haugaard","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.jinf.2005.08.025_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0026-0495(95)90219-8","article-title":"Free insulin-like growth factors in human obesity","volume":"44","author":"Frystyk","year":"1995","journal-title":"Metabolism"},{"key":"10.1016\/j.jinf.2005.08.025_bib26","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1080\/00365540410021162","article-title":"Different growth hormone sensitivity of target tissues and growth hormone response to glucose in hiv-infected patients with and without lipodystrophy","volume":"36","author":"Andersen","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2005.08.025_bib27","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1210\/jcem.85.3.6461","article-title":"Clinical review 112: does serum growth hormone (GH) binding protein reflect human GH receptor function?","volume":"85","author":"Amit","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jinf.2005.08.025_bib28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.0954-6820.1972.tb04826.x","article-title":"Significance of glucose load in oral glucose tolerance tests. Blood glucose, serum insulin, growth hormone and free fatty acids","volume":"192","author":"Christensen","year":"1972","journal-title":"Acta Med Scand"},{"issue":"Suppl 1","key":"10.1016\/j.jinf.2005.08.025_bib29","first-page":"62","article-title":"The role of growth hormone in the regulation of protein metabolism with particular reference to conditions of fasting","volume":"59","author":"Moller","year":"2003","journal-title":"Horm Res"},{"key":"10.1016\/j.jinf.2005.08.025_bib30","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1210\/jc.2003-030267","article-title":"The decisive role of free fatty acids for protein conservation during fasting in humans with and without growth hormone","volume":"88","author":"Norrelund","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jinf.2005.08.025_bib31","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1210\/jcem.87.2.8391","article-title":"Effects of recombinant human growth hormone on hepatic lipid and carbohydrate metabolism in HIV-infected patients with fat accumulation","volume":"87","author":"Schwarz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jinf.2005.08.025_bib32","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1210\/jcem-56-3-608","article-title":"Reduced hepatic insulin extraction in obesity: relationship with plasma insulin levels","volume":"56","author":"Rossell","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jinf.2005.08.025_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-002-1009-0","article-title":"The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes","volume":"46","author":"Kahn","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.jinf.2005.08.025_bib34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/jama.288.2.207","article-title":"Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial","volume":"288","author":"Carr","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jinf.2005.08.025_bib35","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00002030-200404300-00011","article-title":"Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study","volume":"18","author":"Martin","year":"2004","journal-title":"AIDS"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445305002586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445305002586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:29:24Z","timestamp":1758986964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445305002586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0163445305002586"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2005.08.025","relation":{},"ISSN":["0163-4453"],"issn-type":[{"type":"print","value":"0163-4453"}],"subject":[],"published":{"date-parts":[[2006,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth factors, glucose and insulin kinetics after low dose growth hormone therapy in HIV-lipodystrophy","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2005.08.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}